ETF profile for Calamos Timpani Active Smid Growth ETF (CTAG) from the issuer: top holdings, net assets, expense ratio and shares outstanding.
CTAG ETF Profile
| Family: |
Calamos Investments |
| Name: |
Calamos Timpani Active SMID Growth ETF |
|
|
| Inception Date: |
21-Sep-2026 |
| Termination Date: |
|
| Investment Objective: |
Calamos Timpani Active SMID Growth ETF seeks capital appreciation. Under normal circumstances, the Fund invests at least 80% of its net assets in growth equity securities of small and mid-capitalization companies of issuers primarily located in the United States. The Fund defines a small and mid-capitalization company as any company with a market capitalization less than or equal to that of the company with the largest market capitalization of either the Russell 2500 Index or the MSCI USA SMID Cap Index as measured on a rolling 24-month basis over the most recent period. The market capitalization of a security is measured at the time of purchase. Calamos Advisors LLC ("Calamos Advisors") defines "growth" to include any company, security or instrument if any of the following characteristics rank better than average when compared to the Fund's broad-based equity index (long-term projected earnings growth, book value growth, sales growth, cash flow growth and historical earnings growth) or if the company is included as a constituent in any of the growth indices published by third-party index providers or if the security or instrument tracks the performance of a growth index. |
|
|
| Prospectus |
|
|
|
| Top 10 Holdings |
|
|
| Dave, Inc. |
DAVE |
5.8236% |
| US DOLLAR |
|
4.7436% |
| Lumentum Holdings, Inc. |
LITE |
3.9335% |
| Guardant Health, Inc. |
GH |
3.6664% |
| Marex Group, Ltd. |
MRX |
2.8018% |
| Ethos Technologies, Inc. |
LIFE |
2.5298% |
| SiTime Corp. |
SITM |
2.5191% |
| Ligand Pharmaceuticals, Inc. |
LGND |
2.4032% |
| Chime Financial, Inc. |
CHYM |
2.3553% |
| Xometry, Inc. |
XMTR |
2.3016% |
|
Top 10 Holdings Weight: |
33.1% |
| Number of Holdings: |
93 |
| Shares Outstanding: |
2,496,300 |
| Total Net Assets: |
|
| NAV: |
16.24 |
| Net Expense Ratio: |
0.79% |
|
|
| Asset Class: |
Equities (Stocks) |
| Developed or Emerging: |
Developed Market Funds |
| Country: |
US |
| Region: |
|
| Strategy: |
|
| Currency: |
|
| Commodity: |
|
| Sector: |
|
| Industry: |
|
| Dividend Type: |
|
| Tax Exempt State: |
|
| Maturity Duration: |
|
| Market Cap: |
SMID (Small & Mid) Cap |
| Credit Quality: |
|
| Mortgage Bond Types: |
|
| Bond Type: |
|
| Gov't Bond Types: |
|
| Reit Type: |
|
| Leverage Direction/Factor: |
|
| Is Currency Hedged: |
No |
| US or Ex-US: |
Domestic |